7-[(E)-2-[3-(4-tert-Butylphenoxy)phenyl]ethenyl]-3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine

Catalog No. :
ACHMCH864
CAS No. :
866049-97-0
Molecular Formula :
C30H26ClN3O
Molecular Weight :
480.01

IUPAC Name:(E)-7-(3-(4-(tert-butyl)phenoxy)styryl)-3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine

7-[(E)-2-[3-(4-tert-Butylphenoxy)phenyl]ethenyl]-3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-[(E)-2-[3-(4-tert-Butylphenoxy)phenyl]ethenyl]-3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine
IUPAC Name(E)-7-(3-(4-(tert-butyl)phenoxy)styryl)-3-(4-chlorophenyl)pyrazolo[1,5-a]pyrimidine
Molecular FormulaC30H26ClN3O
Molecular Weight480.01
SMILESClC1=CC=C(C2=C3N=CC=C(/C=C/C4=CC=CC(OC5=CC=C(C(C)(C)C)C=C5)=C4)N3N=C2)C=C1
InChI KeyAHEPNUGNLLCAGM-VGOFMYFVSA-N
Synonym7-((E)-2-(3-[4-(TERT-BUTYL)PHENOXY]PHENYL)ETHENYL)-3-(4-CHLOROPHENYL)PYRAZOLO[1,5-A]PYRIMIDINE;4-(TERT-BUTYL)PHENYL 3-((E)-2-[3-(4-CHLOROPHENYL)PYRAZOLO[1,5-A]PYRIMIDIN-7-YL]ETHENYL)PHENYL ETHER;Pyrazolo[1,5-a]pyrimidine, 3-(4-chlorophenyl)-7-[2-[3-[4-(1,1-dimethylethyl)phenoxy]phenyl]ethenyl]-
CAS No.866049-97-0

Synthetic Route by SureRoute

1. ACHMCH864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1 In Stock
  4. Then
  5. ACHMCH864 route product structure diagram
    ACHMCH864866049-97-0
Inquiry

2. ACHMCH864 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHMCH864 route product structure diagram
    ACHMCH864866049-97-0
Inquiry

Comments (0)